Cargando…
Evaluating the performance characteristics of five lateral flow assays for the detection of the SARS-CoV-2 nucleocapsid antigen
In response to the COVID-19 pandemic, lateral flow assays (LFAs) for the detection of SARS-CoV-2 antigen have been proposed as a complementary option to the more costly and time consuming reverse-transcriptase polymerase chain reaction (RT-PCR). We assessed five commercially available SARS-CoV-2 ant...
Autores principales: | Heskin, J., Pallett, S. J. C., Al-Hindawi, A., Davies, G. W., Rayment, M., Mughal, N., Randell, P., Jones, R., Moore, L. S. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130972/ https://www.ncbi.nlm.nih.gov/pubmed/35614181 http://dx.doi.org/10.1038/s41598-022-12805-1 |
Ejemplares similares
-
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
por: Pallett, Scott J.C., et al.
Publicado: (2022) -
Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals.
por: Heskin, Joseph, et al.
Publicado: (2021) -
Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis
por: Lamb, Georgia, et al.
Publicado: (2021) -
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022) -
A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay
por: Grant, Benjamin D., et al.
Publicado: (2021)